Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rang în acțiuni #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Preț acțiune
$2.17
Capitalizare de piață
$249.58M
Schimbare (1 zi)
-1.67%
Schimbare (1 an)
96.34%
Țară
CA
Tranzacționează Cardiol Therapeutics Inc. (CRDL)

Categorie

Istoric al prețului acțiunii pentru Cardiol Therapeutics Inc. (CRDL)
Cel mai mare preț de închidere: $2.19 pe 2026-09-01

Cel mai mic preț de închidere: $3.27 pe 2018-12-01
Istoric al prețului acțiunii pentru Cardiol Therapeutics Inc. din 2018 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 17.16%
2025 -27.01%
2024 53.46%
2023 55.10%
2022 -70.87%
2021 -2.95%
2020 -34.16%
2019 -4.78%
2018 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$171.67 -
DE
$165.71 31.84%
DE
$38.13 25.43%
JP
$21.28 19.62%
IN
$214.46 25.80%
CH